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Pathogenic Vibrio cholerae 01 cause disease by colonizing the human small intes-
tine, where they produce a potent enterotoxin (1). Many elements ofthe vibrio cell
surface havebeen postulated to beinvolved incolonization, butanactual molecular
component or morphological structure responsible for adherence to the human in-
testinal mucosa has not previously been conclusively demonstrated.
In the classical Ogawa V . cholerae 01 strain 395, a regulatory protein, ToxR, con-
trols expression of cholera toxin (2). ToxR also regulates the expression ofa rigid
pilus, TcpA, in a coordinate manner with cholera toxin (3). Recently, tc,6A and toxR
insertion mutants ofV . cholerae Ol were shown tobedefectivein colonization insuckling
mice (3). To determine the role ofTcpA in colonization ofthehuman intestine, the
bacteriology, and clinical and immunologic responses ofhealthy adult volunteers
who ingested three Ogawa 395 mutants were assessed.
Volume 168 October 1988 1487-1492
Materials and Methods
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Bacterial Strains.
￿
Organisms used in this study are listed in Table I. EM of the parent
strain 395 shows expression of TcpA filaments, each 5-7 nm in diameter, aggregating to form
large bundles (3, 4, Fig. 1 A). Strain 395-Nl, an isogenic mutant of 395, has an internal dele-
tion in each of the two genes encoding the A subunit of cholera toxin (5). Strain JJM43,
a derivative of 395-NI, carries an additional deletion in the toxR gene leading to markedly
decreased expression ofTcpA (3). Strain TCP2, also derived from 395-Nl, carries an internal
deletion in the tcpA gene that removes the coding sequence for amino acid residues 119-154
of the 199 residues making up mature TcpA subunits (6); consequently, TCP2 produces
no pili of this type (Fig. 1 B).
Volunteers.
￿
Adult volunteers between the ages of 18 and 35 from the Baltimore metropol-
itan area participated in the studies. The methods of medical screening, care of the volun-
teers, and informed consent have been described (7, 8). Vaccination and challenge studies
were carried out under quarantine in the 32-bed isolation ward maintained by the Center
for Vaccine Development in the University of Maryland Hospital (Baltimore, MD). Pro-
tocols were reviewed by the Human Volunteer Research Committee ofthe University ofMary-
These studies were supported by National Institute of Allergy and Infectious Diseases grants AI-18045
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TABLE I
Classical Vibrio cholerae 01 Ogawa Strains and Derivatives
Tested in Volunteers
land at Baltimore and the Clinical Research Sub-panel of the National Institute of Allergy
and Infectious Diseases.
Bacteriology.
￿
Specimens of all stools were cultured both quantitatively and qualitatively.
If no stool specimen was available in a 24-h period, a rectal swab was obtained. Stool and
swabs were directly plated onto thiosulfate-citrate-bile salts-sucrose (TCBS) agar (BBL
Microbiology Systems, Cockeysville, MD) and inoculated into alkaline peptone water en-
richment broth. After overnight incubation, the enrichment broth was subcultured onto TCBS
agar. Quantitative cultures were obtained by diluting 1.0 g (or 1.0 ml) of stool 10-fold serially
in PBS (pH 7.2), inoculating 0.1 ml onto plates ofTCBS agar, and counting colonies. Yellow
colonies on TCBS agar were confirmed as V . cholerae Ol serotype Ogawa by agglutination
with Ogawatypeing sera. Gelatin string capsule devices (Enterotest; HDC Corp., Mountain
View, CA) were used to obtain duodenal fluid for culture (7). Fasting volunteers ingested
string capsules at 6:00 a.m. on two consecutive days aftervaccination. Strings were removed
4 h later, and the distal bile-stained portions were cultured as above. If the pH of the fluid
obtained from the string was <6, indicating probable gastric origin, negative results were
not reported.
Serology.
￿
Sera were collected from all volunteers before and 7, 21, and 28 d afteringestion
ofall strains. Vibriocidal antibody was measured by a microtiter technique (9). IgG antitoxin
antibodies were measured by ELISA (10).
Results and Discussion
The clinical responses of volunteers to the attenuated strains are summarized in
Table II. Strains TCP2 and 395-N1 (at 106 CFU) were compared in a double-blind
fashion in the same study. Otherwise, the different strains or different doses of the
same strain were tested at separate times. Diarrhea or fever (maximum temperature
of39°C) were documented in 3 of 13 volunteers receiving the higher dose of 395-N1
(108 viable organisms), and constitutional complaints were noted by approximately
half of the recipients of either dose of this strain. Notable adverse reactions were
not seen with strains JJM43 and TCP2.
Dramatic differences were seen in the bacteriologic responses to these strains (Table
II). Recipients of 106 CFU of strains TCP2 or JJM43 never shed the respective or-
ganisms in their stool. Strain JJM43 was recovered from the stools of two of seven
volunteers receiving 2 x 108 CFU, although duodenal string capsule cultures were
negative. In contrast, strain 395-N1 colonized efficiently as determined by coprocul-
tures and cultures of string capsule devices.
20 of 21 recipients of395-N1 had prominent serum vibriocidal antibody responses,
including all 13 volunteers who ingested 108 CFU (Table II). Although 9 of 12
JJM43 recipients also had seroconversions, the geometric mean vibriocidal titers
were significantly lower than those seen after ingestion of 395-N1 (Table II). Like-
wise, the IgG cholera antitoxin responses elicited by JJM43 were significantly lower
when compared with 395-N1 recipients. In distinction, none of eight recipients of
TCP2 manifested significant rises in vibriocidal or antitoxin titers.
Strain Parent Genotype TcpA phenotype
395 ctxA+B' Piliated
395-Nl 395 ctxA- B' Piliated
JJM43 395-NI toxR mutant Decreased expression TcpA pili
TCP2 395-N1 tcpA mutant Absent TcpA piliHERRINGTON ET AL.
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FIGURE 1 .
￿
Electron photomicrographs showing V . cholerae Ol Ogawa 395 (A) and TCP2 (B)
negatively stained with 1% phosphotungstic acid, pH 6.8 . Bundles of TcpA are present only in
strain 395 and are indicated by the arrow.
To assess the induction of protective immunity after immunization with 395-N1
or TCP2, four recipients of 395-N1, three who had received TCP2, and seven con-
trol volunteers were challenged with fully toxigenic V . cholerae Ol strain, Ogawa 395.
Recipients of395-N1 but notTCP2 were protected against clinical cholera(Table III) .
The mechanisms by which V . cholerea 01 adheres to the enterocytes ofthe human
small intestine hasbeen the subject ofintense research since it hasobviousrelevance
to vaccine development (1) . Animal models have previously implicated several com-1490
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ponents of the vibrio surface in attachment and colonization including LPS (11),
flagellar sheath and other flagellar proteins (12), a 25-kD outer membrane protein
named ompV (13, 14), as well as other outer membrane proteins (15) and various
hemagglutinins (16). Taylor et al. recently demonstrated that expression of TcpA
affected thecolonizing capacity ofclassical V cholerae 395 in a mouse model(3). How-
ever, cholera is an infection limitedto the humanhost, and results from animal models
ultimately must be confirmed in man. The studies reported herein are the first un-
controvertible demonstration that a specific vibrio surface structure is essential for
colonization of the human small intestine. Genetic sequences specific for tcpA have
been found in all pathogenic V . cholerae 01 isolates examined (6), suggesting that
toxin-coregulated pili may represent a common mechanism forattachment andcoloni-
zation. Since protection against clinical cholera developed only in those volunteers
who were immunized with strain 395-Nl andnot in thoseingestingthenoncolonizing
derivative TCP2, it is clear that live attenuated, orally administered V . cholerae 01
vaccines should express critical colonization factors such as TcpA. The incorpora-
tion of TcpA and other ToxR-regulated gene products (3, 6) into killed V . cholerae
vaccines mayhave advantages as well. An important future area ofinvestigation will
be the intensive study of the human mucosal response to this colonization factor.
These studies have also shown for the first time that a site-directed mutation in
aregulatory gene (toxR) that controls the expression ofvirulence factors (3) candrasti-
cally reduce the colonization ofthe human host by abacterial pathogen. This result
indicates that the regulation ofvirulence gene expression can play a role as essential
as that played by the structural virulence genes themselves. The importance of coor-
dinate regulatory systems in bacterial pathogenesis is thus demonstrated .
Summary
Isogenic mutant strains of V . cholerae Ol lackingelements of a genetic regulon con-
trolledby toxR and implicated in virulencewere tested in volunteers. A deletion mu-
tation in ctxA, the gene encoding the A subunit of cholera toxin, markedly attenu-
ated disease symptoms without affecting intestinal colonization. Deletion of toxR,
the gene encoding the cholera toxin-positive regulatory protein resulted in a dimi-
nution in colonizing capacity. A deletion mutation in tcpA, encoding the majorsubunit
of thetoxin coregulated pilus (regulated by toxR), abolished the colonizing capacity
TABLE III
Protection against Clinical Cholera Due to Classical 0gawa 395 Conferred by
Prior Administration of Attenuated V. cholerae Strains 395-N1 and TCP2
* Values for 395-N1 recipients lay outside the 95% confidence limits ofthe control group (data
log transformed).
t Approximately 4 wk earlier, these individuals ingested a single dose of 106 viable organisms
with NaHC03.
Group description
No. of volunteers
with diarrhea
Mean diarrheal
stool volume*
ml
Mean number of
diarrheal stools*
Controls 6/7 5,385 15
TCP2 recipients) 2/3 2,954 10
395-Nl recipients$ 1/4 286 31492
￿
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of this strain. These results show for the first time the role of a specific pilus structure
in colonization ofthe human intestine by V . cholerae Ol and exemplify the significance
of a genetic regulon in pathogenesis.
We thank Patricia Spears for technical assistance, and the volunteers who participated in the
clinical trials.
Receivedfor publication 12 July 1988.
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